These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18941234)

  • 41. Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection.
    Miles JJ; Thammanichanond D; Moneer S; Nivarthi UK; Kjer-Nielsen L; Tracy SL; Aitken CK; Brennan RM; Zeng W; Marquart L; Jackson D; Burrows SR; Bowden DS; Torresi J; Hellard M; Rossjohn J; McCluskey J; Bharadwaj M
    J Immunol; 2011 Jan; 186(2):901-12. PubMed ID: 21160049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Late priming and variability of epitope-specific CD8+ T cell responses during a persistent virus infection.
    Kemball CC; Lee ED; Vezys V; Pearson TC; Larsen CP; Lukacher AE
    J Immunol; 2005 Jun; 174(12):7950-60. PubMed ID: 15944301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
    Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design.
    Quadeer AA; Louie RH; Shekhar K; Chakraborty AK; Hsing IM; McKay MR
    J Virol; 2014 Jul; 88(13):7628-44. PubMed ID: 24760894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection.
    Fuller MJ; Shoukry NH; Gushima T; Bowen DG; Callendret B; Campbell KJ; Hasselschwert DL; Hughes AL; Walker CM
    Hepatology; 2010 Feb; 51(2):378-87. PubMed ID: 19918975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
    Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
    Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HCV persistence and immune evasion in the absence of memory T cell help.
    Grakoui A; Shoukry NH; Woollard DJ; Han JH; Hanson HL; Ghrayeb J; Murthy KK; Rice CM; Walker CM
    Science; 2003 Oct; 302(5645):659-62. PubMed ID: 14576438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.
    von Hahn T; Yoon JC; Alter H; Rice CM; Rehermann B; Balfe P; McKeating JA
    Gastroenterology; 2007 Feb; 132(2):667-78. PubMed ID: 17258731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The polyclonal CD8 T cell response to influenza M158-66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutants.
    Petrova GV; Naumova EN; Gorski J
    J Immunol; 2011 Jun; 186(11):6390-7. PubMed ID: 21518969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD8+ T cell tolerance following antigen recognition on hepatocytes.
    Holz LE; Warren A; Le Couteur DG; Bowen DG; Bertolino P
    J Autoimmun; 2010 Feb; 34(1):15-22. PubMed ID: 19744829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of variant specific CD8+ T-cell response against mutant and pre-existing variants leads to outgrowth of particular clones in acute hepatitis C.
    Ulsenheimer A; Paranhos-Baccalà G; Komurian-Pradel F; Raziorrouh B; Kurktschiev P; Diepolder HM; Zachoval R; Spannagl M; Jung MC; Gruener NH
    Virol J; 2013 Sep; 10():295. PubMed ID: 24073713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.
    Lauer GM; Ouchi K; Chung RT; Nguyen TN; Day CL; Purkis DR; Reiser M; Kim AY; Lucas M; Klenerman P; Walker BD
    J Virol; 2002 Jun; 76(12):6104-13. PubMed ID: 12021343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.
    Schmidt J; Iversen AK; Tenzer S; Gostick E; Price DA; Lohmann V; Distler U; Bowness P; Schild H; Blum HE; Klenerman P; Neumann-Haefelin C; Thimme R
    PLoS Pathog; 2012; 8(11):e1003042. PubMed ID: 23209413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunopathogenesis of hepatitis C virus infection.
    Chang KM
    Clin Liver Dis; 2003 Feb; 7(1):89-105. PubMed ID: 12691460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.
    Kaplan DE; Sugimoto K; Newton K; Valiga ME; Ikeda F; Aytaman A; Nunes FA; Lucey MR; Vance BA; Vonderheide RH; Reddy KR; McKeating JA; Chang KM
    Gastroenterology; 2007 Feb; 132(2):654-66. PubMed ID: 17258733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope.
    Neumann-Haefelin C; Timm J; Schmidt J; Kersting N; Fitzmaurice K; Oniangue-Ndza C; Kemper MN; Humphreys I; McKiernan S; Kelleher D; Lohmann V; Bowness P; Huzly D; Rosen HR; Kim AY; Lauer GM; Allen TM; Barnes E; Roggendorf M; Blum HE; Thimme R
    Hepatology; 2010 Jan; 51(1):54-62. PubMed ID: 20034048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.
    Wiegand J; Cornberg M; Aslan N; Schlaphoff V; Sarrazin C; Kubitschke A; Buggisch P; Ciner A; Jaeckel E; Manns MP; Wedemeyer H
    Antivir Ther; 2007; 12(3):303-16. PubMed ID: 17591020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution during the Acute Phase of Infection.
    Peng BJ; Carlson JM; Liu MKP; Gao F; Goonetilleke N; McMichael AJ; Borrow P; Gilmour J; Heath SL; Hunter E; Bansal A; Goepfert PA
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.